SCHEMBL17346396

SCHEMBL17346396

CCC(C)N(CCNCCSC)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 5/20 0.43
SIGMAR1 Q99720 1/20 0.43
BCHE P06276 2/20 0.40
KCNH2 Q12809 3/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 2/20 0.39
ADRA2B P18089 2/20 0.39
ADRA2C P18825 2/20 0.39
SLC6A2 P23975 2/20 0.39
HTR2A P28223 2/20 0.39
ADRA1A P35348 2/20 0.39
SLC6A3 Q01959 2/20 0.39
SLC22A2 O15244 1/20 0.39
SLC22A1 O15245 1/20 0.39
SLC22A3 O75751 1/20 0.39
ESR1 P03372 1/20 0.39
CHRM2 P08172 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17346383 0.87 OPRK1 (0.46) OPRK1SIGMAR1ALDH1A1SMN1; SMN2OPRM1
SCHEMBL17346060 0.87 OPRK1 (0.41) OPRK1SIGMAR1BCHEKCNH2ALDH1A1
SCHEMBL17346092 0.78 REN (0.43) KCNH2ALDH1A1TSHRRENVEGFA
SCHEMBL17346397 0.78 KCNH2 (0.36) KCNH2RENVEGFAEGLN1
SCHEMBL17346334 0.78
SCHEMBL17346181 0.78
SCHEMBL17345892 0.77 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL17346376 0.77 ALDH1A1 (0.39) SIGMAR1BCHEALDH1A1SMN1; SMN2CYP1A2
SCHEMBL17346229 0.77 MAOB (0.43) OPRK1BCHEKCNH2TSHRSLC6A2
SCHEMBL17346303 0.77 CARM1 (0.50) SIGMAR1ALDH1A1TSHRLMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN OPRK1 171/4885SIGMAR1 412/4885BCHE 1165/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN OPRK1 171/4885SIGMAR1 412/4885BCHE 1165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.